Roche Announces Mixed Results For Astegolimab In COPD Trials
21/7 07:33
(RTTNews) - Roche (RHHBY) announced results from two clinical trials evaluating astegolimab in people with moderate to very severe chronic obstructive pulmonary disease or COPD, alongside standard maintenance therapy....